Nature Communications (Dec 2018)

Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis

  • Carlo C. Campa,
  • Rangel L. Silva,
  • Jean P. Margaria,
  • Tracey Pirali,
  • Matheus S. Mattos,
  • Lucas R. Kraemer,
  • Diego C. Reis,
  • Giorgio Grosa,
  • Francesca Copperi,
  • Eduardo M. Dalmarco,
  • Roberto C. P. Lima-Júnior,
  • Silvio Aprile,
  • Valentina Sala,
  • Federica Dal Bello,
  • Douglas Silva Prado,
  • Jose Carlos Alves-Filho,
  • Claudio Medana,
  • Geovanni D. Cassali,
  • Gian Cesare Tron,
  • Mauro M. Teixeira,
  • Elisa Ciraolo,
  • Remo C. Russo,
  • Emilio Hirsch

DOI
https://doi.org/10.1038/s41467-018-07698-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 16

Abstract

Read online

Activation of PI3K plays a role in pulmonary inflammation. Here, the authors develop a drug inhibitor of PI3K, and show that it inhibits lung inflammation and damage in mouse models of asthma and lung fibrosis.